Hypertriglyceridemia: An independent risk factor of chronic kidney disease in Taiwanese adults

American Journal of the Medical Sciences

Volumn 338, Issue 3, 2009, Pages 185-189

  Lee, Pei Hsien ^a   Chang, Hung Yu ^a   Tung, Chun Wu ^a,b   Hsu, Yung Chien ^a   Lei, Chen Chou ^a   Chang, Hsun Hao ^a   Yang, Hsueh Fang ^c   Lu, Long Chuan ^c   Jong, Ming Chung ^d   Chen, Chiu Yueh ^d   Fang, Kuei Ying ^d   Chao, Yu Shiu ^d   Shih, Ya Hsueh ^e   Lin, Chun Liang ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^d Public Health Bureau   (Taiwan)

^e NONE

Author keywords

Chronic kidney disease; End stage renal disease; Hypertriglyceridemia

Indexed keywords

GLUCOSE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEALTH PROGRAM; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TAIWAN; AGED; CHRONIC DISEASE; INCIDENCE; KIDNEY DISEASE; MIDDLE AGED; PREVALENCE;

AGED; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TAIWAN;

EID: 70349243966     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181a92804     Document Type: Article

References (17)

1. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet 2008;371:2173-2182
2. Kuo HW, Tsai SS, Tiao MM, et al. Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007;49:46-55.
3. Zeller K, Whittaker E, Sullivan L, et al. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991;324:78-84.
4. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin- converting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996;334: 939-945
5. Oda H, Keane WF. Recent advances in statins and the kidney. Kidney Int Suppl 1999;71:S2-5.
6. Hypertriglyceridaemia and vascular risk. Report of a meeting of physicians and scientists, University College London Medical School. Lancet 1993;342:781-787
7. Hadjadj S, Duly-Bouhanick B, Bekherraz A, et al. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 2004;30:43-51. (Pubitemid 38418942)
8. Samuelsson O, Mulec H, Knight-Gibson C, et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 1997;12:1908-1915 (Pubitemid 27379464)
9. Pan WH, Flegal KM, Chang HY, et al. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 2004;79:31-39
10. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005;46:871-880 (Pubitemid 41505461)
11. Kaysen GA. Hyperlipidemia in chronic kidney disease. Int J Artif Organs 2007;30:987-992
12. Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol 2008;28:958-973
13. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37-45.
14. Muntner P, Coresh J, Smith JC, et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000;58:293-301. (Pubitemid 30429874)
15. Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 2008;52:39-48. (Pubitemid 351853265)
16. Rifkin DE, Shlipak MG, Katz R, et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008;168:2212-2218
17. Hwang SJ, Lin MY, Chen HC, et al. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Nephrol Dial Transplant 2008;23:3192-3198